Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
11/06/2002 | EP1254172A1 Nucleic acids, proteins, and antibodies |
11/06/2002 | EP1254167A2 Preparation of deallergenized patatin proteins and patatin permutein proteins |
11/06/2002 | EP1254157A1 Nucleic acids, proteins, and antibodies |
11/06/2002 | EP1254153A2 Nucleic acids, proteins, and antibodies |
11/06/2002 | EP1254152A2 Nucleic acids, proteins, and antibodies |
11/06/2002 | EP1254151A1 Nucleic acids, proteins, and antibodies |
11/06/2002 | EP1254147A2 Nucleic acids, proteins, and antibodies |
11/06/2002 | EP1254141A1 Camptothecin -beta-alanine esters with topoisomerase i inibhition |
11/06/2002 | EP1254108A1 Gamma-secretase inhibitors |
11/06/2002 | EP1253937A2 Methods of therapy with thrombin derived peptides |
11/06/2002 | EP1253932A2 Botulinum toxin pharmaceutical compositions |
11/06/2002 | EP1253823A1 Controlling offspring's sex ratio by targeting transgenes onto the sex chromosomes |
11/06/2002 | EP1007718A4 Polymerase enhancing factor (pef) extracts, pef protein complexes, isolated pef protein, and methods for purifying and identifying |
11/06/2002 | EP0748382B1 Non-nucleotide containing enzymatic nucleic acid |
11/06/2002 | EP0650520B1 Process for the production of saccharose-synthase |
11/06/2002 | EP0635025B1 Process for preparing modified proteins |
11/06/2002 | CN1378602A Plants with modified poly unsaturated fatty acids |
11/06/2002 | CN1378600A Nucleic acid molecules derived from plants whihc code for enzymes which are involved in synthesis of starch |
11/06/2002 | CN1378598A Evolution and use of enzymes for combinathorial and medicinal chemistry |
11/06/2002 | CN1378593A Method and compostions for construction and use of fusion libraries |
11/06/2002 | CN1377969A Prourokinase variant capable of being activated by urokinase or itself and its coding gene, preparing method and use |
11/06/2002 | CN1377961A Ring structure ribo-enzyme and deoxy-ribozyme and their use |
11/06/2002 | CN1377960A Two kinds of evolution enzyme of human ribonuclease and human lycozyme |
11/06/2002 | CN1093880C Stabilization of carboxyl esterase |
11/05/2002 | WO2000077220A2 Method of modifying peptide synthetases such that they can n-methylate their substrate amino acids |
11/05/2002 | US6476295 Expression of sucrose phosphorylase in plants |
11/05/2002 | US6476294 Plant phosphatidic acid phosphatases |
11/05/2002 | US6476293 Use of bacterial acetate kinase and their genes for protection of plants against different pathogens |
11/05/2002 | US6476211 Methods and materials relating to CD39-like polypeptides |
11/05/2002 | US6476210 Human kinases and polynucleotides encoding the same |
11/05/2002 | US6476200 Mammalian proteins that bind to FKBP12 in a rapamycin-dependent fashion |
11/05/2002 | US6476193 NLK1 protein and NLK1 protein complexes |
11/05/2002 | US6476190 Process for preparing modified proteins |
11/05/2002 | US6476042 Combination therapy for the treatment of migraine |
11/05/2002 | US6475996 Use of a vector expressing DNA polymerase β as medicine |
11/05/2002 | US6475789 Human telomerase catalytic subunit: diagnostic and therapeutic methods |
11/05/2002 | US6475784 Inhibition of angiogenesis by delivery of nucleic acids encoding anti-angiogenic polypeptides |
11/05/2002 | US6475768 Xylose isomerase with improved properties |
11/05/2002 | US6475767 Process for producing L-methionine γ-lyase crystals |
11/05/2002 | US6475766 Human osteoclast-derived cathepsin |
11/05/2002 | US6475765 Subtilisin DY variants having decreased adsorption and increased hydrolysis |
11/05/2002 | US6475764 Recombinant collagenase type I from clostridium histolyticum and its use for isolating cells and groups of cells |
11/05/2002 | US6475763 Genetically modified cells and methods for expressing recombinant heparanase and methods of purifying same |
11/05/2002 | US6475762 Phytase enzymes nucleic acids encoding phytase enzymes and vectors and host cells incorporating same |
11/05/2002 | US6475761 Glycosyltransferase and DNA encoding the same |
11/05/2002 | US6475734 Polyhydroxyalkanoate synthase genes |
11/05/2002 | US6475487 Treatment of a patient by administering an antibody that inhibits cathepsin O |
11/05/2002 | US6475485 Two novel human cathepsin proteins |
11/05/2002 | US6475484 Recombinant antibacterial group IIA phospholipase A2 and methods of use thereof |
11/05/2002 | US6475140 Flexible pressure resistant cover for the articulation system of a medical instrument |
11/05/2002 | CA2418798A1 Method of modifying peptide synthetases such that they can n-methylate their substrate amino acids |
11/05/2002 | CA2069437C Process for control of fruit ripening in plants |
11/04/2002 | EP1163324A4 Genetically modified plants having modulated brassinosteroid signaling |
11/03/2002 | CA2384605A1 Granule-bound starch synthase |
11/01/2002 | CA2380804A1 Method for producing cytosine nucleosides compounds |
10/31/2002 | WO2002086170A1 Tankyrase h, compositions involved in the cell cycle and methods of use |
10/31/2002 | WO2002086165A1 Biological sample processing methods and compositions that include surfactants |
10/31/2002 | WO2002086152A1 Non-recombinant cell lines capable of expressing predominantly cyclic nucleotide phophodiesterase 4 (pde4) subtype b and their use for the screening of pde4 subtype-specific modulators |
10/31/2002 | WO2002086145A2 Biological sample processing methods and compositions that include surfactants |
10/31/2002 | WO2002086138A2 Transformation of (di)amines in the presence of a lysine oxidase and a reducing agent |
10/31/2002 | WO2002086137A2 Process for the production of l-amino acids by fermentation using coryneform bacteria |
10/31/2002 | WO2002086128A2 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
10/31/2002 | WO2002086126A2 Enzymatic method for the enantioselective reduction of keto compounds |
10/31/2002 | WO2002086119A1 Transformed silkworm producing human collagen |
10/31/2002 | WO2002086116A1 Sulfated fucoglucuronomannan |
10/31/2002 | WO2002086115A1 Active site inactivators |
10/31/2002 | WO2002086114A1 Lipoxygenase |
10/31/2002 | WO2002086113A2 Enzyme and snp marker for disease |
10/31/2002 | WO2002086112A2 Nucleic acid molecules encoding starch degrading enzymes |
10/31/2002 | WO2002086111A2 Recombinant alpha-amino ester hydrolases and uses thereof |
10/31/2002 | WO2002086110A2 Flavone synthase i enzymes and the use thereof |
10/31/2002 | WO2002086094A2 Genes involved in isoprenoid compound production |
10/31/2002 | WO2002086092A2 N-methyltransferase |
10/31/2002 | WO2002086091A2 Method to treat hemophilia by hepatic gene transfer of factor viii/ix with vesicle vector |
10/31/2002 | WO2002086088A2 Polymerases with charge-switch activity and methods of generating such polymerases |
10/31/2002 | WO2002086085A2 Human timp-1 antibodies |
10/31/2002 | WO2002086075A2 Methods and composition for the production of orthoganal trna-aminoacyltrna synthetase pairs |
10/31/2002 | WO2002086067A2 Mycobacterial sulfation pathway proteins and methods of use thereof |
10/31/2002 | WO2002086058A2 Method for producing catalytic antibodies (variants), antigens for immunisation and nucleotide sequence |
10/31/2002 | WO2002085923A2 In vivo incorporation of unnatural amino acids |
10/31/2002 | WO2002085388A1 Ca2+/calmodulin-dependent protein kinase iv |
10/31/2002 | WO2002085337A1 Micellar drug delivery systems for hydrophobic drugs |
10/31/2002 | WO2002085094A2 Transgenic mice containing acylphosphatase gene disruptions |
10/31/2002 | WO2002070659A9 Production of polyhydroxyalkanoates |
10/31/2002 | WO2002068595A3 Mono-and diacylglycerol acyltransferases and methods of use thereof |
10/31/2002 | WO2002064814A3 Expression of human milk proteins in transgenic plants |
10/31/2002 | WO2002057433A9 Homeodomain-interacting protein kinases and the use of the same for influencing cell division and cell proliferation |
10/31/2002 | WO2002055713A3 58848, a human protein kinase family member and uses therefor |
10/31/2002 | WO2002054066A3 Non-apoptotic forms of cell death and methods of modulation |
10/31/2002 | WO2002046377A9 Abscisic acid 8'- and 7'- hydroxylase genes and related sequences from plants |
10/31/2002 | WO2002042489A9 Methods involving a t cell protein tyrosine phosphatase |
10/31/2002 | WO2002040652A3 Novel soluble endoproteases for the in vitro processing of recombinant proteins |
10/31/2002 | WO2002040544A3 Mutant human factor ix with an increased resistance to inhibition by heparin |
10/31/2002 | WO2002040045A3 Microspheres of pancreatic enzymes with high stability |
10/31/2002 | WO2002034913A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
10/31/2002 | WO2002031127A3 Cloning and recombinant expression of mammalian group xii secreted phospholipase a¿2? |
10/31/2002 | WO2002026769A3 Haplotypes of the casp5 gene |
10/31/2002 | WO2002018560A3 Butinol i esterase |
10/31/2002 | WO2002016566A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
10/31/2002 | WO2002016563A3 14189, a human kinase and uses thereof |